{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:55:04Z","timestamp":1792814104323,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the associated risk of cervical intraepithelial neoplasm grade 3+ (CIN3+) lesions in patients with AGC and extensive human papillomavirus (HPV) genotyping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cases with atypical glandular cell (AGC) interpretation on a Papanicolaou (Pap) test were identified along with associated extensive HPV genotyping and histologic follow-up results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within this cohort of 469,694 Pap tests, 0.4% were diagnosed as AGCs. In total, 1267 cases had concurrent high-risk HPV (hrHPV) genotyping, and 40.3% were hrHPV positive. The percentage of AGC cases with cervical CIN3+ on histologic follow-up was 52.2% when hrHPV was positive, whereas it was 4.9% with a negative hrHPV result. The top 5 hrHPV genotypes associated with cervical CIN3+ in this cohort were HPV16, HPV18, HPV58, HPV52, and HPV33. Indeed, 92.8% of the hrHPV-associated CIN3+ lesions identified in this cohort were positive for at least one of these HPV genotypes. The sensitivity of detecting cervical CIN3+ lesions was 85.6% with the top 5 hrHPV genotypes (HPV16\/18\/58\/52\/33) and only increased to 89.0% when the additional 12 genotypes were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with an AGC Pap, the risk of having a cervical CIN3+ lesion is greatly increased by positivity for hrHPV types 16, 18, 58, 52, and\/or 33. Incorporating comprehensive HPV genotyping into AGC cytology allows for refined risk stratification and more tailored management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqae103","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T17:33:34Z","timestamp":1720892014000},"page":"134-142","source":"Crossref","is-referenced-by-count":8,"title":["The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells"],"prefix":"10.1093","volume":"163","author":[{"given":"Xiao","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L","family":"Zilla","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center , Pittsburgh, PA ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Starr","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center , Pittsburgh, PA ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutie","family":"Yin","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education , Chengdu ,","place":["China"]},{"name":"Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7524-3048","authenticated-orcid":false,"given":"Chengquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center , Pittsburgh, PA ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"issue":"2","key":"2025012906105884000_CIT0001","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3322\/canjclin.51.2.92","article-title":"Cervical cancer: prevention, diagnosis, and therapeutics","volume":"51","author":"Janicek","year":"2001","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"2025012906105884000_CIT0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K","article-title":"Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases","volume":"93","author":"Krane","year":"2001","journal-title":"Cancer."},{"issue":"5","key":"2025012906105884000_CIT0003","doi-asserted-by":"publisher","first-page":"666","DOI":"10.5858\/arpa.2016-0234-CP","article-title":"False-negative interpretation of adenocarcinoma in situ in the College of American Pathologists Gynecologic PAP Education Program","volume":"141","author":"Zhao","year":"2017","journal-title":"Arch Pathol Lab Med."},{"key":"2025012906105884000_CIT0004","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","author":"Nayar","year":"2015","edition":"3"},{"issue":"1","key":"2025012906105884000_CIT0005","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s44197-023-00172-7","article-title":"Global cervical cancer incidence by histological subtype and implications for screening methods","volume":"14","author":"Wang","year":"2024","journal-title":"J Epidemiol Glob Health"},{"issue":"8","key":"2025012906105884000_CIT0006","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1136\/ijgc-2019-000556","article-title":"Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer","volume":"29","author":"Cao","year":"2019","journal-title":"Int J Gynecol Cancer."},{"issue":"843262","key":"2025012906105884000_CIT0007","article-title":"Survival of patients with cervical cancer treated with definitive radiotherapy or concurrent chemoradiotherapy according to histological subtype: a systematic review and meta-analysis","volume":"9","author":"Yao","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"2025012906105884000_CIT0008","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis."},{"issue":"11","key":"2025012906105884000_CIT0009","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/ijc.34242","article-title":"Atypical glandular cells and development of cervical cancer: population-based cohort study","volume":"151","author":"Norman","year":"2022","journal-title":"Int J Cancer."},{"issue":"1","key":"2025012906105884000_CIT0010","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ijc.27663","article-title":"Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies","volume":"132","author":"Guan","year":"2013","journal-title":"Int J Cancer."},{"issue":"5","key":"2025012906105884000_CIT0011","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.3802\/jgo.2017.28.e50","article-title":"Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study","volume":"28","author":"Sun","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2025012906105884000_CIT0012","doi-asserted-by":"publisher","first-page":"e28302","DOI":"10.1002\/jmv.28302","article-title":"Extended human papillomavirus genotype distribution in cervical intraepithelial neoplasia and cancer: analysis of 40 352 cases from a large academic gynecologic center in China","volume":"95","author":"Tang","year":"2023","journal-title":"J Med Virol."},{"issue":"9","key":"2025012906105884000_CIT0013","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7150\/jca.14971","article-title":"Prevalence and genotype distribution of HPV Infection in China: analysis of 51,345 HPV genotyping results from China\u2019s largest CAP Certified Laboratory","volume":"7","author":"Zeng","year":"2016","journal-title":"J Cancer"},{"issue":"1","key":"2025012906105884000_CIT0014","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/dc.20589","article-title":"Weeding atypical glandular cell look-alikes from the true atypical lesions in liquid-based Pap tests: a review","volume":"35","author":"Wood","year":"2007","journal-title":"Diagn Cytopathol."},{"issue":"3","key":"2025012906105884000_CIT0015","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cncy.21791","article-title":"Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: analysis of 1857 cases from an academic institution","volume":"125","author":"Patadji","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"2025012906105884000_CIT0016","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/AOG.0000000000005286","article-title":"Assessment of human papillomavirus non-16\/18, type-specific risk for cervical intraepithelial neoplasia grade 3 or worse among women with cervical atypical glandular cells","volume":"142","author":"Yilmaz","year":"2023","journal-title":"Obstet Gynecol."},{"issue":"2","key":"2025012906105884000_CIT0017","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.29424","article-title":"High-risk HPV testing in the management of atypical glandular cells: a systematic review and meta-analysis","volume":"138","author":"Verdoodt","year":"2016","journal-title":"Int J Cancer."},{"issue":"8","key":"2025012906105884000_CIT0018","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncy.21724","article-title":"Clinical significance of atypical glandular cells in Pap tests: an analysis of more than 3000 cases at a large academic women\u2019s center","volume":"124","author":"Pradhan","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"2025012906105884000_CIT0019","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"2025012906105884000_CIT0020","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/cam4.1321","article-title":"Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset","volume":"7","author":"Bao","year":"2018","journal-title":"Cancer Med"},{"issue":"15","key":"2025012906105884000_CIT0021","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jama.2020.16244","article-title":"Lifetime prevalence of cervical cancer screening in 55 low- and middle-income countries","volume":"324","author":"Lemp","year":"2020","journal-title":"JAMA."},{"issue":"10175","key":"2025012906105884000_CIT0022","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0140-6736(18)32849-6","article-title":"Cervical cancer prevention in China: a key to cancer control","volume":"393","author":"Zhao","year":"2019","journal-title":"Lancet."},{"issue":"10","key":"2025012906105884000_CIT0023","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/07357907.2021.1952593","article-title":"The clinical significance and utility of HPV-DNA testing in Korean women with atypical glandular cells in cervical Pap tests: an analysis of 311 cases at a single institution","volume":"39","author":"Jang","year":"2021","journal-title":"Cancer Invest."},{"issue":"5-6","key":"2025012906105884000_CIT0024","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000490230","article-title":"Significance of high-risk human papillomavirus testing for atypical glandular cells on cervical cytology","volume":"62","author":"Komatsu","year":"2018","journal-title":"Acta Cytol."},{"issue":"2","key":"2025012906105884000_CIT0025","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jcv.2013.08.006","article-title":"Prevalence and genotype distribution of human papillomavirus in cytology specimens containing atypical glandular cells: a case-control study","volume":"58","author":"Namugenyi","year":"2013","journal-title":"J Clin Virol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/1\/134\/58758351\/aqae103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/1\/134\/58758351\/aqae103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:11:06Z","timestamp":1738113066000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/163\/1\/134\/7729081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,7]]},"published-print":{"date-parts":[[2025,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqae103","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,8,7]]}}}